Carbon dioxide methanol → HCID 90088627, compound
Reaction equation
[F:1][C:2]1[CH:3]=[C:4]([C:8]2[C:9]3[CH:30]=[CH:29][CH:28]=[C:27]([CH3:31])[C:10]=3[NH:11][C:12](=[O:26])[CH:13]([NH:15][C:16](=[O:25])[O:17][CH2:18][C:19]3[CH:24]=[CH:23][CH:22]=[CH:21][CH:20]=3)[N:14]=2)[CH:5]=[CH:6][CH:7]=1.C(=O)=O.CO>>[F:1][C:2]1[CH:3]=[C:4]([C:8]2[C:9]3[CH:30]=[CH:29][CH:28]=[C:27]([CH3:31])[C:10]=3[NH:11][C:12](=[O:26])[C@@H:13]([NH:15][C:16](=[O:25])[O:17][CH2:18][C:19]3[CH:24]=[CH:23][CH:22]=[CH:21][CH:20]=3)[N:14]=2)[CH:5]=[CH:6][CH:7]=1Participants
Procedure
Racemic benzyl (5-(3-fluorophenyl)-9-methyl-2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)carbamate (5.9 g, 14.3 mmol) was resolved under the Chiral SFC conditions. Berger SFC MGIII, Column: CHIRALPAK® IC 25×3 cm ID, 5 μm, Mobile Phase: 45/55 CO2/MeOH; Flow rate: 160 mL/min; Detector wavelength: 220 nM. The desired stereoisomer was collected as the second peak in the elution order. After evaporation of solvent, (S)-benzyl (5-(3-fluorophenyl)-9-methyl-2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)carbamate (2.73 g, 46% yield) was obtained as a white solid. HPLC: RT=3.075 min Purity=99%. (H2O/MeOH with TFA, CHROMOLITH® ODS S5 4.6×50 mm, gradient=4 min, wavelength=220 nm). Chiral HPLC RT: 8.661 min(AD, 60% (EtOH/MeOH)/heptane)>99% ee. (on AD chiral column desired is the first peak, which is the second peak on the IC SFC).
Workup
- customThe desired stereoisomer was collected as the second peak in the elution order
- customAfter evaporation of solvent
Sources & evidence
- ORD record
- ord-b0eabd0cdfe149fdbe8d1d32f17f0cd0
- Source dataset
- uspto-grants-2015_09
- Patent number
- US09133139B2
Reaction notes
Loading…